What is Reliefband Technologies?
Reliefband Technologies specializes in innovative, drug-free wearable technology for the prevention and treatment of nausea and vomiting. Their FDA-cleared devices employ patented technology to safely stimulate the nervous system, offering an effective alternative to medication for conditions like motion sickness, morning sickness, and chemotherapy-induced nausea. The company's commitment to safety, efficacy, and rapid relief has garnered trust among a broad user base, including pregnant women, migraine sufferers, and individuals managing anxiety, with their products also finding application in clinical settings.
How much funding has Reliefband Technologies raised?
Reliefband Technologies has raised a total of $7.8M across 3 funding rounds:
Private Equity
$1.8M
Private Equity
$5M
Debt
$1M
Private Equity (2015): $1.8M, investors not publicly disclosed
Private Equity (2015): $5M, investors not publicly disclosed
Debt (2017): $999K, investors not publicly disclosed
What's next for Reliefband Technologies?
The recent major strategic investment positions Reliefband Technologies for accelerated growth and market expansion. This capital infusion is expected to fuel further research and development, enhance manufacturing capabilities, and broaden the company's market reach. With a strong foundation in drug-free therapeutic technology, Reliefband is poised to solidify its leadership in the wearable health device market and explore new applications for its patented system, potentially leading to further enterprise-level funding rounds as it scales.
See full Reliefband Technologies company page
